|
2023
|
Invention
|
Inhibitors of the menin-mll interaction.
The present invention is directed to inhibitors of the ... |
|
2022
|
Invention
|
Inhibitors of the menin-mll interaction.
The present disclosure is directed to inhibitors of For... |
|
|
Invention
|
Inhibitors of the menin-mll interaction. The present disclosure is directed to inhibitors of Form... |
|
2021
|
Invention
|
Inhibitors of ror gamma.
The present disclosure relates to salts and crystalline forms of a comp... |
|
|
Invention
|
Inhibitors of rorgamma.
The present disclosure relates to processes for the production of salts ... |
|
2020
|
Invention
|
Modulators of ror-gamma.
Provided are indole, benzoimidazole, pyrrolopyridine, and imidazopyridi... |
|
|
Invention
|
Modulators of ror-gamma.
Provided are novel compounds of Formula I
Provided are novel compound... |
|
|
Invention
|
Dihydropyrrolopyridine inhibitors of ror-gamma. Provided are novel compounds of Formula (I):
ph... |
|
|
Invention
|
Inhibitors of the menin-mll interaction. The present invention is directed to inhibitors of the i... |
|
|
Invention
|
Dihydropyrrolopyridine inhibitors of ror-gamma.
Provided are novel compounds of Formula (I):
P... |
|
2019
|
Invention
|
Liver x receptor modulators.
Provided herein are novel compounds and pharmaceutically acceptable... |
|
|
Invention
|
Substituted benzoimidazoles as modulators of ror-γ. Provided are indole, benzoimidazole, pyrrolop... |
|
2018
|
Invention
|
Inhibitors of ror gamma. The present disclosure relates to salts and crystalline forms of a compo... |
|
|
Invention
|
Inhibitors of ror.gamma.. The present disclosure relates to processes for the production of salts... |
|
|
Invention
|
Dihydropyrrolopyridine inhibitors of ror-gamma. Provided are novel compounds of Formula (I):
... |
|
|
Invention
|
Compounds for use in treating acute coronary syndrome and related conditions.
Provided herein ar... |
|
2017
|
Invention
|
Dihydropyrrolopyridine inhibitors of rorγ. Provided are novel compounds of Formula (I):
γ. Also ... |
|
|
Invention
|
Benzimidazole derivatives as modulators of ror-gamma. Provided are novel compounds of Formula I: ... |
|
2016
|
Invention
|
Modulators of ror-gamma. Provided are novel compounds of Formula I: pharmaceutically acceptable s... |
|
|
Invention
|
Dihydropyrrolopyridine inhibitors of ror-gamma. Provided are novel compounds of Formula (I):
. A... |
|
|
Invention
|
Substituted indoles as modulators of ror-gamma. Provided are novel compounds of Formula I: pharma... |
|
|
Invention
|
Liver x receptor modulators. Provided herein are novel compounds and pharmaceutically acceptable ... |
|
2015
|
Invention
|
Isoindoline inhibitors of ror-gamma. Provided are novel compounds of Formula (I):
pharmaceutica... |
|
|
Invention
|
Inhibitors of beta-secretase. The present invention is directed to a compound represented by the ... |
|
|
Invention
|
Dihydropyrrolopyridine inhibitors of ror-gamma. Provided are novel compounds of Formula (I): phar... |
|
|
Invention
|
Piperazine derivatives as liver x receptor modulators. Provided are novel compounds of Formula (I... |
|
2014
|
Invention
|
Thiazolopyrrolidine inhibitors of ror- γ. Provided are novel compounds of Formula (I): pharmaceut... |
